Emmis Acquisition Corp. Class A Company Profile
NASDAQ: EMISHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Emmis Acquisition at a glance
Emmis Acquisition Corp. Class A (NASDAQ: EMIS) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Fort Lauderdale, FL. Emmis Acquisition is led by Mr. Peter Joseph Goldstein M.B.A.. The company's shares have traded publicly since 2025.
At a market capitalization of $163.4 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002075816, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Emmis Acquisition do?
Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on target companies primarily in the service, manufacturing, and distribution sectors, including industrial, business, educational, financial, healthcare, and software services in Southeast Asia and North America. Emmis Acquisition Corp. was incorporated in 2025 and is based in Fort Lauderdale, Florida.
Business description based on the company's public filings.
Company information
- Legal name
- Emmis Acquisition Corp. Class A
- Ticker
- NASDAQ: EMIS
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Peter Joseph Goldstein M.B.A.
- Headquarters
- 515 E Las Olas Boulevard, Fort Lauderdale, FL, United States
- Phone
- 201 282 6717
- Website
- emmisacquisition.com
- IPO year
- 2025
- Market cap
- $163.36M
- SEC CIK
- 0002075816
- Latest annual report
- 10-K · Mar 27, 2026
Companies similar to Emmis Acquisition
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ABEOAbeona Therapeutics Inc. | 2.42 | -1.22% | $165.31M | vs EMIS |
| KRROKorro Bio Inc. | 12.18 | -0.08% | $167.18M | vs EMIS |
| TRDAEntrada Therapeutics Inc. | 4.35 | -6.25% | $170.30M | vs EMIS |
| ORMPOramed Pharmaceuticals Inc. | 3.57 | -3.25% | $155.24M | vs EMIS |
| SIGASIGA Technologies Inc. | 2.40 | -9.43% | $172.45M | vs EMIS |
| IFRXInflaRx N.V. | 1.04 | -4.59% | $153.26M | vs EMIS |
| VOGXVogenx Inc | 11.87 | -7.30% | $176.33M | vs EMIS |
| ELDNEledon Pharmaceuticals Inc. | 1.78 | -6.32% | $150.34M | vs EMIS |